These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
685 related items for PubMed ID: 19389429
1. Variations in illumination, closed wall transparency and/or extramaze space influence both baseline anxiety and response to diazepam in the rat elevated plus-maze. Violle N, Balandras F, Le Roux Y, Desor D, Schroeder H. Behav Brain Res; 2009 Oct 12; 203(1):35-42. PubMed ID: 19389429 [Abstract] [Full Text] [Related]
2. A comparison between Dark Agouti and Sprague-Dawley rats in their behaviour on the elevated plus-maze, open-field apparatus and activity meters, and their response to diazepam. Mechan AO, Moran PM, Elliott M, Young AJ, Joseph MH, Green R. Psychopharmacology (Berl); 2002 Jan 12; 159(2):188-95. PubMed ID: 11862348 [Abstract] [Full Text] [Related]
3. An approach to evaluate the ability of rats to discriminate different levels of illumination in the plus maze test: effects of scopolamine. de Araújo Godinho MA, Meneghini L, Lucinda AM, Borges FR, Sakae DY, Marino Neto J, Paschoalini MA, de Lima TC, Faria MS. Behav Brain Res; 2007 Jun 04; 180(1):86-94. PubMed ID: 17408761 [Abstract] [Full Text] [Related]
4. Anxiolytic-like effects of ginseng in the elevated plus-maze model: comparison of red ginseng and sun ginseng. Park JH, Cha HY, Seo JJ, Hong JT, Han K, Oh KW. Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jul 04; 29(6):895-900. PubMed ID: 16002200 [Abstract] [Full Text] [Related]
5. Higher detection sensitivity of anxiolytic effects of diazepam by ledge-free open arm with opaque walled closed arm elevated plus maze in male rats. Horii Y, Kawaguchi M. Behav Brain Res; 2015 Nov 01; 294():131-40. PubMed ID: 26241172 [Abstract] [Full Text] [Related]
6. Age-related qualitative shift in emotional behaviour: paradoxical findings after re-exposure of rats in the elevated-plus maze. Bessa JM, Oliveira M, Cerqueira JJ, Almeida OF, Sousa N. Behav Brain Res; 2005 Jul 01; 162(1):135-42. PubMed ID: 15922074 [Abstract] [Full Text] [Related]
7. Light/dark cycle manipulation influences mice behaviour in the elevated plus maze. Clénet F, Bouyon E, Hascoët M, Bourin M. Behav Brain Res; 2006 Jan 06; 166(1):140-9. PubMed ID: 16165231 [Abstract] [Full Text] [Related]
8. The benzodiazepine diazepam demonstrates the usefulness of Syrian hamsters as a model for anxiety testing: evaluation of other classes of anxiolytics in comparison to diazepam. Gannon RL, Lungwitz E, Batista N, Hester I, Huntley C, Peacock A, Delagrange P, Millan MJ. Behav Brain Res; 2011 Mar 17; 218(1):8-14. PubMed ID: 21094664 [Abstract] [Full Text] [Related]
9. The anterior cingulate cortex is a target structure for the anxiolytic-like effects of benzodiazepines assessed by repeated exposure to the elevated plus maze and Fos immunoreactivity. Albrechet-Souza L, Borelli KG, Carvalho MC, Brandão ML. Neuroscience; 2009 Dec 01; 164(2):387-97. PubMed ID: 19699782 [Abstract] [Full Text] [Related]
10. A comparative study with two types of elevated plus-maze (transparent vs. opaque walls) on the anxiolytic effects of midazolam, one-trial tolerance and fear-induced analgesia. Albrechet-Souza L, Oliveira AR, De Luca MC, Tomazini FM, Santos NR, Brandão ML. Prog Neuropsychopharmacol Biol Psychiatry; 2005 May 01; 29(4):571-9. PubMed ID: 15866360 [Abstract] [Full Text] [Related]
11. Anxiolytic effects of Echium amoenum on the elevated plus-maze model of anxiety in mice. Rabbani M, Sajjadi SE, Vaseghi G, Jafarian A. Fitoterapia; 2004 Jul 01; 75(5):457-64. PubMed ID: 15261383 [Abstract] [Full Text] [Related]
12. Increases in plasma corticosterone and stretched-attend postures in rats naive and previously exposed to the elevated plus-maze are sensitive to the anxiolytic-like effects of midazolam. Albrechet-Souza L, Cristina de Carvalho M, Rodrigues Franci C, Brandão ML. Horm Behav; 2007 Aug 01; 52(2):267-73. PubMed ID: 17553501 [Abstract] [Full Text] [Related]
13. Acute effect of Copaifera reticulata Ducke copaiba oil in rats tested in the elevated plus-maze: an ethological analysis. Curio M, Jacone H, Perrut J, Pinto AC, Filho VF, Silva RC. J Pharm Pharmacol; 2009 Aug 01; 61(8):1105-10. PubMed ID: 19703355 [Abstract] [Full Text] [Related]
14. Kaempferol from the leaves of Apocynum venetum possesses anxiolytic activities in the elevated plus maze test in mice. Grundmann O, Nakajima J, Kamata K, Seo S, Butterweck V. Phytomedicine; 2009 Apr 01; 16(4):295-302. PubMed ID: 19303276 [Abstract] [Full Text] [Related]
15. Concurrent nociceptive stimulation impairs the anxiolytic effect of midazolam injected into the periaqueductal gray in mice. Mendes-Gomes J, Nunes-de-Souza RL. Brain Res; 2005 Jun 14; 1047(1):97-104. PubMed ID: 15893297 [Abstract] [Full Text] [Related]
16. Effect of different illumination levels on rat behavior in the elevated plus-maze. Garcia AM, Cardenas FP, Morato S. Physiol Behav; 2005 Jun 30; 85(3):265-70. PubMed ID: 15927214 [Abstract] [Full Text] [Related]
17. Effect of the selective 5-HT7 receptor antagonist SB 269970 in animal models of anxiety and depression. Wesołowska A, Nikiforuk A, Stachowicz K, Tatarczyńska E. Neuropharmacology; 2006 Sep 30; 51(3):578-86. PubMed ID: 16828124 [Abstract] [Full Text] [Related]
18. The elevated T-maze task as an animal model to simultaneously investigate the effects of drugs on long-term memory and anxiety in mice. Asth L, Lobão-Soares B, André E, Soares Vde P, Gavioli EC. Brain Res Bull; 2012 Apr 10; 87(6):526-33. PubMed ID: 22394406 [Abstract] [Full Text] [Related]
19. Behavioral effects of the beta3 adrenoceptor agonist SR58611A: is it the putative prototype of a new class of antidepressant/anxiolytic drugs? Consoli D, Leggio GM, Mazzola C, Micale V, Drago F. Eur J Pharmacol; 2007 Nov 14; 573(1-3):139-47. PubMed ID: 17669397 [Abstract] [Full Text] [Related]
20. Does rat global transient cerebral ischemia serve as an appropriate model to study emotional disturbances? Bantsiele GB, Bentué-Ferrer D, Amiot N, Allain H, Bourin M, Reymann JM. Fundam Clin Pharmacol; 2004 Dec 14; 18(6):685-92. PubMed ID: 15548240 [Abstract] [Full Text] [Related] Page: [Next] [New Search]